Johnson & Johnson avoided damaging verdicts in two trials this week alleging its baby powder caused mesothelioma.

In California, a jury rendered a defense verdict, giving Johnson & Johnson the upper hand in the litigation alleging its asbestos-containing talcum powder products caused mesothelioma, a deadly form of lung cancer. Until then, there were eight previous trials. Two ended with defense verdicts, most recently last month in New Jersey, while juries have awarded $25.75 million and $117 million to plaintiffs. The remaining cases ended in mistrials, most recently in South Carolina, where a jury Thursday deliberated a full day before coming back deadlocked at 11-1.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]